SMAD4 loss is associated with response to neoadjuvant chemotherapy plus hydroxychloroquine in patients with pancreatic adenocarcinoma-Reference-Cited by-同舟云学术

SMAD4 loss is associated with response to neoadjuvant chemotherapy plus hydroxychloroquine in patients with pancreatic adenocarcinoma

Published:2021-05-18 Issue:5 Volume:14 Page:1822-1829
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clinical Translational Sci

Author:

Fei Naomi¹,Wen Sijin²,Ramanathan Rajesh³,Hogg Melissa E.⁴,Zureikat Amer H.⁵,Lotze Michael T.⁵,Bahary Nathan⁶,Singhi Aatur D.⁷,Zeh Herbert J.⁸,Boone Brian A.⁹¹⁰

Affiliation:

1. Division of Hematology/Oncology Department of Medicine West Virginia University Morgantown West Virginia USA

2. Department of Biostatistics School of Public Health West Virginia University Morgantown West Virginia USA

3. Department of Surgery Banner MD Anderson Cancer Center Phoenix Arizona USA

4. Division of Surgical Oncology Department of Surgery Northshore University Health System Chicago Illinois USA

5. Division of Surgical Oncology Department of Surgery University of Pittsburgh Pittsburgh Pennsylvania USA

6. Division of Hematology/Oncology Department of Medicine University of Pittsburgh Pittsburgh Pennsylvania USA

7. Department of Pathology University of Pittsburgh Pittsburgh Pennsylvania USA

8. Division of Surgical Oncology Department of Surgery UT Southwestern Dallas Texas USA

9. Division of Surgical Oncology Department of Surgery West Virginia University Morgantown West Virginia USA

10. Department of Microbiology, Immunology and Cell Biology West Virginia University Morgantown West Virginia USA

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.13029

Reference41 articles.

1. Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors

2. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes

3. SMAD4 Gene Mutation Renders Pancreatic Cancer Resistance to Radiotherapy through Promotion of Autophagy

4. Autophagy Inhibition in Pancreatic Adenocarcinoma

5. Autophagy sustains the survival of human pancreatic cancer PANC-1 cells under extreme nutrient deprivation conditions

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Echinacoside ameliorates hepatic fibrosis and tumor invasion in rats with thioacetamide-induced hepatocellular carcinoma;Biomolecules and Biomedicine;2024-09-06

2. Pharmacology Progresses and Applications of Chloroquine in Cancer Therapy;International Journal of Nanomedicine;2024-07

3. SBRT for Pancreatic Cancer: A Radiosurgery Society Case-Based Practical Guidelines to Challenging Cases;Practical Radiation Oncology;2024-07

4. Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic Cancer;Current Issues in Molecular Biology;2024-03-23

5. An NFATc1/SMAD3/cJUN Complex Restricted to SMAD4-Deficient Pancreatic Cancer Guides Rational Therapies;Gastroenterology;2024-02